Clinical trials
Active, not recruiting Phase 2 Anxiety Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brown University | 1 |
| Dana-Farber Cancer Institute | 1 |
| IGC Pharma, LLC | 1 |
| Institut Claudius Regaud | 1 |
| Mclean Hospital | 1 |
| Orygen | 1 |
| University of California, San Diego | 1 |
| University of Florida | 1 |
| University of Washington | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anxiety Disorders | 9 |
| Alzheimer Disease | 1 |
| COVID-19 | 1 |
| Dementia | 1 |
| Generalized Anxiety Disorder | 1 |
| Marijuana Abuse | 1 |
| Neoplasm Metastasis | 1 |
| Parasomnias | 1 |
| Psychomotor Agitation | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.